Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2513-2026

Beta Bionics, Inc. recalls iLet Bionic Pancreas

Beta Bionics, Inc.Irvine, CA, United StatesReported Jun 24, 2026 · 24 days ago
Legal News Analyst ·

Reason for recall

The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

iLet Bionic Pancreas1 code
  • BB1001

Lot / code information

iLet ACE Pump firmware BOM000072 Rev C (version 3.3.6) and BOM000072 Rev B (version 3.3.4)

What the firm is doing

On 3/12/2026, recall notices were mailed and emailed to customers who were informed of the following: On September 23, 2025, Beta Bionics, Inc. issued an Urgent Medical Device Correction notification to customers informing them of the lock screen software issue and software upgrade. These problems are resolved in newer host software versions (3.3.7 and up). Please check your software version and update your software as soon as possible. Update your software 1. Download or update your iLet app on your phone. Need help! Read the iLet App User Guide. 2. Log into your iLet app. 3. Position your iLet next to your phone with the app open. 4. Go to app settings on the iLet app and follow the on-screen instructions to update to the latest firmware. 5. Complete the acknowledgement survey at https://sprw.io/stt-3tkjI or If you have any questions, please call the firm's Customer Care at 1-855-745-3800 option 1.

DistributionShow details

US: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC, CT, MN, VA, OK, AR, AZ, MO, MT, RI, DC, NM, OR, ID, NV, AK, ND, DE, WV, WY, SD, UT, AL

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls